is rybelsus a glp-1 drug Comparing Ozempic, Wegovy and Other Drugs Popular obesity drug fails in

In crude analyses, GLP-1 receptor agonist use was associated with an increased incidence of suicidality compared with DPP-4 inhibitors (crude incidence rates 3.9 v 1.8 per 1000 person years, respectively

We used version 2 of the Cochrane risk-of-bias tool for randomised trials to assess risk of bias for the primary outcome

Participation in this program does not replace healthy lifestyle habits, including balanced nutrition and regular movement

Healthy people are injecting tiny doses of obesity medication to look and feel even better

Weight loss, whether resulting from disease-related conditions or intentional interventions, has been increasingly recognized as a significant risk factor for compromised skeletal integrity

Given that there are now GLP-1 pills, I'm wondering if the adoption curve will change